Project Grant R35GM155015

Award Date 9/10/24
Completion Date 7/31/29
Dollars Obligated $751K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Houston, TX 77005, USA
Similar Awards
The National Science Foundation (NSF) awarded a $500,000 Project Grant to the University of California, San Diego (UCSD) under the Engineering (CFDA #47.041) program to design, fabricate, and evaluate acoustic-to-optical nanoscale transducers. The goal of this 3-year project is to develop novel micro-auscultation devices that can efficiently convert weak sound waves into optical signals, enabling the detection and interpretation of acoustic signatures from small biological objects like cells,...
This $332,826 Project Grant awarded by the National Science Foundation's Engineering (CFDA 47.041) program to Lehigh University supports the development of a compact, portable, and accurate digital biosensing system enabled by localized acoustic streaming. The goal is to create an integrated testing platform that can detect low-abundance nucleic acid and protein biomarkers without requiring dedicated instruments or laboratory space, enabling high-quality medical testing in underserved and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a novel in-line biomanufacturing process analytical technology tool. The $302,417 award to Physical Sciences Inc. (PSI), in collaboration with the University of Massachusetts Lowell (UML), aims to enable real-time monitoring of biomolecules in large-scale bioreactors for gene therapy manufacturing. The technology...
The National Institute of General Medical Sciences (NIGMS) has awarded a $389,653 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Research Foundation for the State University of New York (RF-SUNY), doing business as Rf-SUNY At The University At Albany. This 5-year project, starting on January 1, 2025, aims to develop a transdisciplinary research program centered around AI-supported biosensing and precision therapeutics using DNA nanotechnology and...
This federal Project Grant award of $306,788 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports the development of advanced probe technologies for ultrasensitive RNA imaging using hybridization chain reaction (HCR) methods. The awardee, Molecular Instruments, Inc., is a for-profit manufacturer of specialized scientific instruments and probes for biological research and imaging....
This $3,000,000 project grant, awarded by the National Science Foundation (NSF) under the Engineering (CFDA 47.041) program, aims to solve the long-standing challenge of developing self-amplifying ribonucleic acid (SARNA) technologies. The project, led by Trustees of Boston University, a private non-profit research university, will: Synthesize a diverse library of modified nucleoside triphosphates (ModNTPs) and use them to produce modified SARNA with extended cellular half-life. Evaluate the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $275,000 will support the development of a plasmonic nanopore sensor device for quality control of adeno-associated viruses (AAVs) used in gene therapy. The proposed device will enable accurate characterization of AAV payload (single-stranded DNA, double-stranded DNA, or empty) at low, pre-scale-up concentrations to optimize formulations. The project aims to demonstrate the...
This Project Grant award, provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a microchip-based technology for advanced cell engineering. The $305,000 award to Cellecho, Inc., with a project period from April 2025 to March 2026, will fund the design and optimization of a miniaturized instrument that leverages sound waves and electric fields to manipulate cells and deliver genetic materials. This innovation...
The National Science Foundation (NSF) awarded a $300,000 Project Grant under its Biological Sciences program (CFDA 47.074) to the Georgia TECH Research Corporation for the "TOOLS4CELLS: EAGER: A MOLECULAR PURSUIT FOR THE ENGRAM: MICROFLUIDIC TEMPORAL TRANSCRIPTOMICS FOR SINGLE CELL LEARNING" project. This 2-year effort aims to develop innovative microfluidic tools and workflows to investigate the role of non-coding RNA in learning and memory storage in single-celled organisms. Key...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), is focused on developing a novel high-throughput, high-content imaging platform for analyzing extracellular vesicles (EVs) at the single-particle level. The $298,999 award to Numentus Technologies Inc. will fund the construction, testing, and application of this platform to detect and characterize EV subpopulations, including...

NEXT-GENERATION DESIGN OF ACOUSTIC REPORTER GENES WITH OPTIMAL ASSEMBLY - PROJECT SUMMARY / ABSTRACT THE ABILITY TO VISUALIZE SPECIFIC GENE EXPRESSION, EXEMPLIFIED BY METHODS LIKE GREEN FLUORESCENT PROTEIN (GFP) REPORTERS, HAS BEEN PIVOTAL IN SCIENTIFIC RESEARCH OVER THE PAST FEW DECADES. HOWEVER, MOST OF THESE TECHNIQUES RELY ON OPTICS, AND ARE THEREFORE LIMITED BY THE ~1 MM PENETRATION DEPTH OF LIGHT INTO BIOLOGICAL TISSUES. IT IS IN THIS CONTEXT THAT A CLASS OF AIR-FILLED PROTEIN NANOSTRUCTURES NAMED GAS VESICLES (GVS) WERE DEVELOPED AS THE FIRST ACOUSTIC REPORTER GENES, WHICH ENABLED THE USE OF ULTRASOUND TO IMAGE GENE EXPRESSION IN CELLS LOCATED IN CENTIMETER-DEEP TISSUES. SINCE THEN, BIOMOLECULAR ENGINEERING OF GVS HAS RAPIDLY EXPANDED THE USE OF THESE UNIQUE AIR-FILLED PROTEIN NANOSTRUCTURES INTO DIRECTIONS SUCH AS SPATIALLY CELLULAR CONTROL, DRUG DELIVERY, PRESSURE SENSING, GAS DELIVERY, NEUROMODULATION, AND MULTIMODAL IMAGING. DESPITE THE RAPID PROGRESS IN THE BIOMEDICAL APPLICATIONS OF GVS, THE UNDERSTANDING OF THE GENETICS AND BIOPHYSICS UNDERLYING GV FORMATION LAGS BEHIND, AND IT HAS BEEN RECOGNIZED THAT THE ASSEMBLY OF GVS IN NON-NATIVE HOST ORGANISMS IS FAR FROM OPTIMAL COMPARED TO THAT IN THE NATIVE HOST CELLS. THIS GAP POSES A SIGNIFICANT, UNIVERSAL OBSTACLE IN ALMOST ALL GV-BASED TECHNOLOGIES, STRONGLY HINDERING THEIR ADAPTABILITY AND APPLICATION. OUR RESEARCH PROGRAM AIMS TO ADDRESS THIS CHALLENGE BY PURSUING TWO PARALLEL DIRECTIONS. IN THE FIRST, WE DELVE INTO THE FUNDAMENTAL SCIENCE TO UNRAVEL THE MOLECULAR MECHANISM OF GV ASSEMBLY. IN THE SECOND, WE FOCUS ON ENGINEERING CONTROL, USING SYNTHETIC BIOLOGY STRATEGIES TO DESIGN GENETIC CONSTRUCTS THAT ACHIEVE OPTIMAL GV ASSEMBLY. IF SUCCESSFUL, THE DISCOVERIES FROM THESE PROJECTS WILL NOT ONLY ENHANCE OUR FUNDAMENTAL UNDERSTANDING OF THIS INTRIGUING CLASS OF PROTEIN ORGANELLES, BUT ALSO REVOLUTIONIZE THE BIOMOLECULAR ENGINEERING OF GVS, WHICH WILL GENERATE A MAJOR IMPACT FOR ALL THE BIOMEDICAL APPLICATIONS OF THIS CLASS OF NANOSTRUCTURES IN MOLECULAR IMAGING, CELLULAR CONTROL, THERANOSTIC NANO-AGENTS, AND BIOSENSING.

Posted 9/4/24